VANCOUVER, British Columbia--(BUSINESS WIRE)--Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today ...
Vancouver firm's AI platform will generate chemical compounds based on Merck’s therapeutic targets. A Vancouver startup using artificial intelligence (AI) to discover new drugs has struck a deal with ...
Hosted on MSN
Variational raises $50 million Series A to bring liquidity from traditional markets to blockchain rails
The crypto industry has long defined itself in opposition to traditional finance but, in recent years, the two worlds are on a path to convergence. The latest example is Variational, a startup that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results